- Home
- TSAT vs ZVRA Comparison
TSAT vs ZVRA Comparison
Compare TSAT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- ZVRA
- Stock Information
- Founded
- TSAT 1969
- ZVRA 2006
- Country
- TSAT Canada
- ZVRA United States
- Employees
- TSAT N/A
- ZVRA N/A
- Industry
- TSAT Metal Fabrications
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TSAT Industrials
- ZVRA Health Care
- Exchange
- TSAT Nasdaq
- ZVRA Nasdaq
- Market Cap
- TSAT 515.2M
- ZVRA 467.6M
- IPO Year
- TSAT 1996
- ZVRA 2015
- Fundamental
- Price
- TSAT $30.29
- ZVRA $10.18
- Analyst Decision
- TSAT
- ZVRA Strong Buy
- Analyst Count
- TSAT 0
- ZVRA 7
- Target Price
- TSAT N/A
- ZVRA $22.57
- AVG Volume (30 Days)
- TSAT 145.1K
- ZVRA 1.8M
- Earning Date
- TSAT 11-04-2025
- ZVRA 11-05-2025
- Dividend Yield
- TSAT N/A
- ZVRA N/A
- EPS Growth
- TSAT N/A
- ZVRA N/A
- EPS
- TSAT N/A
- ZVRA N/A
- Revenue
- TSAT $358,754,564.00
- ZVRA $62,020,000.00
- Revenue This Year
- TSAT N/A
- ZVRA $336.43
- Revenue Next Year
- TSAT N/A
- ZVRA $54.26
- P/E Ratio
- TSAT N/A
- ZVRA N/A
- Revenue Growth
- TSAT N/A
- ZVRA 161.81
- 52 Week Low
- TSAT $10.11
- ZVRA $6.19
- 52 Week High
- TSAT $36.85
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- TSAT 50.80
- ZVRA 47.76
- Support Level
- TSAT $30.30
- ZVRA $10.03
- Resistance Level
- TSAT $31.83
- ZVRA $11.23
- Average True Range (ATR)
- TSAT 1.79
- ZVRA 0.56
- MACD
- TSAT -0.60
- ZVRA -0.14
- Stochastic Oscillator
- TSAT 14.57
- ZVRA 7.41
About TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.